Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Purified or recombinant proteins for HIV infection available for licensing

Nov. 26, 1996

Purified or recombinant protein for HIV infection and cancer offered for licensing

Nov. 26, 1996

Anti-HIV drug now available in U.K.

Nov. 26, 1996

LeukoSite and Warner-Lambert collaborate on drugs blocking the CCR5 receptor

Nov. 22, 1996

Japanese researchers disclose anti-HIV agents

Nov. 22, 1996

French market introduction for Epivir

Nov. 21, 1996

New anti-HIV agents discovered by Hoechst

Nov. 19, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

Viral load markedly reduced by Invirase + Norvir

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...